Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- methylene blue
- Utibron Neohaler (glycopyrrolate / indacaterol)
Interactions between your drugs
methylene blue indacaterol
Applies to: methylene blue, Utibron Neohaler (glycopyrrolate / indacaterol)
Using indacaterol together with methylene blue may increase cardiovascular side effects such as heart palpitations, chest pain, increased heart and pulse rates, and blood pressure elevations. The risk exists even when indacaterol or similar medications are given by oral inhalation directly into the lungs, and more so if these products are overused. Talk to your doctor before using these medications if you have a history of heart disease or high blood pressure. Depending on your condition, it may be preferable to wait at least 14 days after you are off methylene blue before you start using indacaterol. Do not exceed the dose and frequency of use of indacaterol recommended on the product label or prescribed by your doctor. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
glycopyrrolate food
Applies to: Utibron Neohaler (glycopyrrolate / indacaterol)
Ask your doctor before using glycopyrrolate together with ethanol (alcohol). Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while you are taking glycopyrrolate. You should be warned not to exceed recommended dosages and to avoid activities requiring mental alertness. If your doctor prescribes these medications together, you may need a dose adjustment to safely take this combination. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Xifaxan
Xifaxan (rifaximin) is used to treat travelers' diarrhea, irritable bowel syndrome with diarrhea ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Vitamin B1
Vitamin B1 is used for beriberi, vitamin b1 deficiency, vitamin/mineral supplementation and ...
Constulose
Constulose is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Enulose
Enulose is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Duphalac
Duphalac is a laxative used to treat chronic constipation by drawing water into the colon ...
Kristalose
Kristalose is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Generlac
Generlac is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.